Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand

Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for customers.